top of page
GeneToBe News
September 14, 2022
GeneToBe Receives Funding via Convertible Note
August 2022
GeneToBe Converts Michigan LLC to Delaware Corporation
August 2021
GeneToBe licenses patents for a Cystic Fibrosis treatment technology from University of Michigan Read News+
February 01, 2021
Dr. Michael Iannuzzi joins team as Chief Medical Officer Read More+
January 14, 2021
CRISPR: three new developments in the world of gene editing Read News+
December 04, 2020
Advancing Gene Editing With New CRISPR/Cas9 Variant Read News+
Cas9 modification can improve efficiency of gene editing Read News+
CRISPR Medicine News Read News+
X-MOL Read Article+
December 03, 2020
Advancing Gene Editing With New CRISPR/Cas9 Variant Read News+
January 2020
GeneToBe forms LLC
Patent Estate
U.S. Serial No. 62/895,800
U.S. Serial No. 62/948,660
U.S. Serial No. 63/152,727
PCT application PCT/US2020/049369
Helpful Resources
CRISPR/Cas9 Technology
https://www.synthego.com/blog/gene-editing-nobel-prize#charpentier-and-doudna-win-nobel-prize-in-chemistry-for-developing-crispr-technology
https://www.nature.com/collections/txhdfslxzh/videos
Cystic Fibrosis Foundation
Cystic Fibrosis Gene Editing
https://www.youtube.com/watch?v=nWj7Be6PSS4
Foundation for Fighting Blindness
https://www.fightingblindness.org
Usher III Initiative
Usher Syndrome Coalition
https://www.usher-syndrome.org/
Usher Syndrome (U.S. National Library of Medicine)
https://ghr.nlm.nih.gov/condition/usher-syndrome
What is Gene Therapy? (U.S. National Library of Medicine)
https://ghr.nlm.nih.gov/primer/therapy/genetherapy
bottom of page